Recent genome-wide association study (GWAS) results indicate that APOE2 may offer protection from AD risk by differentially regulating protein phosphatase 2A (PP2A), an important tau phosphatase in the human brain, unlike the detrimental impact of APOE4 [66,67]. The gene discussed is APOE; the disease is Alzheimer disease.